scholarly journals Survival impact of incidence of lymph node metastases and radical resection for duodenal neuroendocrine tumors: analyses of the national cancer database 2004-2016

HPB ◽  
2021 ◽  
Vol 23 ◽  
pp. S653
Author(s):  
Y. Fujii ◽  
C.W. Tzeng ◽  
Y.J. Chiang ◽  
D.M. Halperin ◽  
A. Dasari ◽  
...  
Keyword(s):  
Lymph Node ◽  
Neuroendocrine Tumors ◽  
Lymph Node Metastases ◽  
Radical Resection ◽  
National Cancer Database ◽  
Node Metastases ◽  
Duodenal Neuroendocrine Tumors

Incidence of Lymph Node Metastases and Impact of Radical Surgery for Duodenal Neuroendocrine Tumors

2021 ◽  
Vol 268 ◽  
pp. 419-431
Author(s):  
Yuki Fujii ◽  
Ching-Wei Tzeng ◽  
Yi-Ju Chiang ◽  
Daniel M. Halperin ◽  
Arvind Dasari ◽  
...  
Keyword(s):  
Lymph Node ◽  
Neuroendocrine Tumors ◽  
Lymph Node Metastases ◽  
Radical Surgery ◽  
Node Metastases ◽  
Duodenal Neuroendocrine Tumors

scholarly journals Prognostic Significance of Lymph Node Metastases in Small Intestinal Neuroendocrine Tumors

2015 ◽  
Vol 101 (1) ◽  
pp. 58-65 ◽  
Author(s):  
Michelle Kang Kim ◽  
Richard R.P. Warner ◽  
Stephen C. Ward ◽  
Noam Harpaz ◽  
Sasan Roayaie ◽  
...  
Keyword(s):  
Lymph Node ◽  
Neuroendocrine Tumors ◽  
Lymph Node Metastases ◽  
Prognostic Significance ◽  
Node Metastases ◽  
Small Intestinal

The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management

Surgery ◽  
2019 ◽  
Vol 166 (1) ◽  
pp. 15-21 ◽  
Author(s):  
Alexandra G. Lopez-Aguiar ◽  
Cecilia G. Ethun ◽  
Mohammad Y. Zaidi ◽  
Flavio G. Rocha ◽  
George A. Poultsides ◽  
...  
Keyword(s):  
Lymph Node ◽  
Surgical Management ◽  
Neuroendocrine Tumors ◽  
Risk Score ◽  
Lymph Node Metastases ◽  
Pancreatic Neuroendocrine Tumors ◽  
Preoperative Risk ◽  
Node Metastases

1201 Clinical and Pathologic Risk Factors for Lymph Node Metastases in Gastric Neuroendocrine Tumors

2019 ◽  
Vol 114 (1) ◽  
pp. S675-S675
Author(s):  
Jonathan Ragheb ◽  
Firas Bahdi ◽  
Neal Mehta ◽  
Robert Butler ◽  
Prabhleen Chahal ◽  
...  
Keyword(s):  
Risk Factors ◽  
Lymph Node ◽  
Neuroendocrine Tumors ◽  
Lymph Node Metastases ◽  
Node Metastases

Neuroendocrine Tumors of Meckel's Diverticula: Rare but Fare Well

2019 ◽  
Vol 85 (10) ◽  
pp. 1125-1128 ◽  
Author(s):  
James P. De Andrade ◽  
Andrew M. Blakely ◽  
Andrew H. Nguyen ◽  
Philip H. G. Ituarte ◽  
Susanne G. Warner ◽  
...  
Keyword(s):  
Lymph Node ◽  
Neuroendocrine Tumors ◽  
Lymphovascular Invasion ◽  
Metastatic Lymph Node ◽  
National Cancer Database ◽  
Tumor Characteristics ◽  
Node Disease ◽  
Node Metastases ◽  
Well Differentiated ◽  
Common Malignancy

Neuroendocrine tumors (NETs) are the most common malignancy arising in Meckel's diverticula (MDs). To date, there are no large series characterizing these tumors. The National Cancer Database was queried for patients with MD NETs (n = 162) from 2004 to 2014. Patient and tumor characteristics as well as outcomes were analyzed. MD NETs were more common in men (72.8%) at a median age of 62 years; 95.1 per cent of patients were white. All patients underwent surgery. Clinical M0 disease was present in 97.4 per cent of patients, and 88.2 per cent of tumors were well differentiated. Lymphovascular invasion was present in 13.2 per cent. Most (60.4%) tumors were less than 10 mm. Lymphadenectomy was performed in 32.9 per cent of patients, with 52.1 per cent of these found to have metastatic lymph node disease. Although most MD NETs are well differentiated, smaller than 10 mm, and do not have lymphovascular invasion, lymph node metastases are commonly found, suggesting that mesenteric lymphadenectomy with adequate resection of the small bowel may be necessary for adequate staging and disease clearance.

Sign in / Sign up

Export Citation Format

Share Document